Close Asset Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-7
Closed 275
2024
Q2
$0 Sell
7
-90
-93% -$1.79K ﹤0.01% 278
2024
Q1
$2K Buy
+97
New +$1.67K ﹤0.01% 249
2023
Q3
Sell
-100
Closed -$2K 257
2023
Q2
$2K Hold
100
﹤0.01% 239
2023
Q1
$2K Hold
100
﹤0.01% 229
2022
Q4
$3K Hold
100
﹤0.01% 186
2022
Q3
$2K Hold
100
﹤0.01% 176
2022
Q2
$3K Sell
100
-101
-50% -$3.54K ﹤0.01% 178
2022
Q1
$6K Hold
201
﹤0.01% 190
2021
Q4
$6K Sell
201
-150
-43% -$4.89K ﹤0.01% 190
2021
Q3
$12K Sell
351
-109
-24% -$3.49K ﹤0.01% 182
2021
Q2
$14K Buy
+460
New +$15.1K ﹤0.01% 170

Other funds holding OGN

Close Asset Management's OGN Position: Q3 2024 in Review

Close Asset Management sold out of Organon & Co (OGN) in Q3 2024, closing a stake of 7 shares.

Close Asset Management first reported a position in OGN in Q2 2021 and held it in 11 quarters. The position peaked at $14K in Q2 2021. 724 funds tracked by Wall St. Rank hold OGN as of Q3 2024.

  • Close Asset Management reported no remaining Organon & Co position as of Q3 2024 after selling out during the quarter.
  • Close Asset Management sold 7 Organon & Co shares in Q3 2024.
  • Close Asset Management first reported a position in Organon & Co in Q2 2021 and held it in 11 quarters.
  • Close Asset Management's Organon & Co position peaked at $14K in Q2 2021.
  • 724 funds tracked by Wall St. Rank held Organon & Co as of Q3 2024.

Based on Close Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.